rhgalectin-9 (Galectin Therapeutics)
90
Structured Review
Galectin Therapeutics
rhgalectin-9
Rhgalectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhgalectin-9/rhgalectin+9/pm40090006-646-15-15
Average 90 stars, based on 1 article reviews
Rhgalectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhgalectin-9/rhgalectin+9/pm40090006-646-15-15
Average 90 stars, based on 1 article reviews
rhgalectin-9 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Crocin Bleaching Assay:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Control:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Recombinant:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Western Blot:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Cell Culture:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Expressing:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and Comparison:Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: ELISA and CBA revealed that the rhGalectin‐9 induced increased production of TGF‐β, but decreased secretion of IFN‐γ and IL‐17 by Tim‐3 + CD4 + T cells, compared with Article Title: Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis Article Snippet: JING KANG, ZHI-FENG WEI, MING-XIAN LI and JING-HUA WANG* Department of Respiratory, The First Hospital of Jilin University, Changchun 130021, People’s Republic of China Jilin Medical University, Jilin 132013, People’s Republic of China Department of Cardiology, Jilin Province FAW General Hospital, Changchun 130011, People’s Republic of China Department of Pediatric Rheumatology, Immunology and Allergy, the First Hospital of Jilin University, Changchun 130021, People’s Republic of China Article Title: Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance Article Snippet: The group treated with Article Title: A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia. Article Snippet: GAPDH was used as a 756 housekeeping control. (G) CAR19-T cell-mediated cytotoxicity against non-transduced and |